This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rodriguez, E. Articles by Chaganti, R. S. K. Search for Related Content PubMed PubMed Citation Articles by Rodriguez, E. Articles by Chaganti, R. S. K.

Cytogenetic Analysis of 124 Prospectively Ascertained Male Germ Cell Tumors¹

Laboratory of Cancer Genetics, Sloan-Kettering Institute [E. R., S. M., R. S. K. C.], and the Departments of Pathology [V. R., R. S. K. C.] and Medicine [G. J. B.], Memorial Hospital, Memorial Sloan-Kettering Cancer Center, New York, New York 10021

We report the cytogenetic analysis of 124 adult male germ cell tumors ascertained consecutively at the Memorial Sloan-Kettering Cancer Center between 1988 and 1990. Biopsies from testicular and extragonadal primary and metastatic lesions studied included all histological subtypes of germ cell tumors and cases of malignant transformation. Nonrandom numerical and structural chromosomal abnormalities including i(12p), the previously described characteristic marker of these tumors, were determined, and their frequency was compared between histological subtypes, between gonadal and extragonadal lesions, and between primary and transformed lesions. The frequency and copy number of i(12p) were found to be higher in nonseminomas compared with seminomas. Nonrandom sites of chromosome rearrangements associated with specific histologies comprised 1p32–36 and 7q11.2 in teratomas and 1p22 in yolk sac tumors. Some tumors that underwent malignant differentiation exhibited chromosome changes previously described to be nonrandomly associated with de novo tumors with the same histological characteristics. Cytological evidence of gene amplification in the form of homogeneously staining regions and/or double minutes was detected in 24% of extragonadal lesions, mainly metastatic tumors, suggesting amplification of a gene(s) associated with metastatic progression of these tumors. While a number of previous small cytogenetic series or individual case reports of germ cell tumors identified several of the features of these tumors reported here, this series comprises analysis of the largest group of tumors ascertained consecutively at a single institution, defines the incidence of nonrandom abnormalities in tumor subsets, and addresses their biological significance.

¹ Supported in part by NIH Research Grant CA-05826.

² To whom requests for reprints should be addressed, at Box 391, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.

Received 9/24/91. Accepted 2/ 4/92.

This article has been cited by other articles:

				J. Houldsworth, J. E. Korkola, G. J. Bosl, and R. S. K. Chaganti Biology and Genetics of Adult Male Germ Cell Tumors J. Clin. Oncol., December 10, 2006; 24(35): 5512 - 5518. [Abstract] [Full Text] [PDF]

				E. Rajpert-De Meyts Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects Hum. Reprod. Update, May 1, 2006; 12(3): 303 - 323. [Abstract] [Full Text] [PDF]

				I. M. Veltman, L. A. Vreede, J. Cheng, L. H.J. Looijenga, B. Janssen, E. F.P.M. Schoenmakers, E. T.H. Yeh, and A. G. van Kessel Fusion of the SUMO/Sentrin-specific protease 1 gene SENP1 and the embryonic polarity-related mesoderm development gene MESDC2 in a patient with an infantile teratoma and a constitutional t(12;15)(q13;q25) Hum. Mol. Genet., July 15, 2005; 14(14): 1955 - 1963. [Abstract] [Full Text] [PDF]

				A. C. Donadio, R. J. Motzer, D. F. Bajorin, P. W. Kantoff, J. Sheinfeld, J. Houldsworth, R. S.K. Chaganti, and G. J. Bosl Chemotherapy for Teratoma With Malignant Transformation J. Clin. Oncol., December 1, 2003; 21(23): 4285 - 4291. [Abstract] [Full Text] [PDF]

				K. K. Youngren, J. H. Nadeau, and A. Matin Testicular cancer susceptibility in the 129.MOLF-Chr19 mouse strain: additive effects, gene interactions and epigenetic modifications Hum. Mol. Genet., February 15, 2003; 12(4): 389 - 398. [Abstract] [Full Text] [PDF]

				D. T. Schneider, A. E. Schuster, M. K. Fritsch, J. Hu, T. Olson, S. Lauer, U. Gobel, and E. J. Perlman Multipoint Imprinting Analysis Indicates a Common Precursor Cell for Gonadal and Nongonadal Pediatric Germ Cell Tumors Cancer Res., October 1, 2001; 61(19): 7268 - 7276. [Abstract] [Full Text] [PDF]

				B. A. Schmidt, A. Rose, C. Steinhoff, T. Strohmeyer, M. Hartmann, and R. Ackermann Up-Regulation of Cyclin-dependent Kinase 4/Cyclin D2 Expression but Down-Regulation of Cyclin-dependent Kinase 2/Cyclin E in Testicular Germ Cell Tumors Cancer Res., May 1, 2001; 61(10): 4214 - 4221. [Abstract] [Full Text]

				V. V.V.S. Murty, K. Montgomery, S. Dutta, S. Bala, B. Renault, G. J. Bosl, R. Kucherlapati, and R. S.K. Chaganti A 3-Mb High-Resolution BAC/PAC Contig of 12q22 Encompassing the 830-kb Consensus Minimal Deletion in Male Germ Cell Tumors Genome Res., July 1, 1999; 9(7): 662 - 671. [Abstract] [Full Text]

				G. J. Bosl and R. J. Motzer Testicular Germ-Cell Cancer N. Engl. J. Med., July 24, 1997; 337(4): 242 - 254. [Full Text] [PDF]